Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Answering Trump, UPS, FedEx and USPS say they already fight illegal drug shipments

Published 08/23/2019, 05:38 PM
Updated 08/23/2019, 05:38 PM
© Reuters. A Federal Express delivery truck is shown in downtown Los Angeles

By Lisa Baertlein and Ankit Ajmera

(Reuters) - FedEx Corp (N:FDX), United Parcel Service Inc (N:UPS) and the U.S. Postal Service said on Friday they are already working to stop traffickers from using their services after U.S. President Donald Trump ordered delivery firms to refuse packages of the powerful painkiller fentanyl from China.

Trump told those shippers and online retailer Amazon.com Inc (O:AMZN) to decline deliveries of the synthetic opioid from China, which on Friday announced new retaliatory tariffs on a swath of U.S. goods.

"I am ordering all carriers, including Fed Ex, Amazon, UPS and the Post Office, to SEARCH FOR & REFUSE all deliveries of Fentanyl from China (or anywhere else!)," Trump said on Twitter.

"President Xi said this would stop - it didn’t," he tweeted, referring to China's President Xi Jinping.

Fentanyl is 50 times more powerful than heroin and is contributing to the nation's deadliest drug crisis in history.

Shares of FedEx, UPS and Amazon were each down at least 3% after the latest salvo in the U.S.-China trade war sent the U.S. stock market lower.

"We work closely with all law enforcement and regulatory authorities to monitor for prohibited substances," UPS said.

Rival FedEx said in a statement it "already has extensive security measures in place to prevent the use of our networks for illegal purposes."

Private delivery companies like UPS and FedEx electronically track packages, which has deterred some drug dealers, who have exploited the gaps in the USPS' tracking system.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

"The most common distribution medium is via the U.S. Postal Service," the U.S. Treasury said in a statement on Wednesday, when it announced sanctions against a trio of Chinese nationals accused of trafficking illegal fentanyl.

Drug traffickers target U.S. ports of entry and international mail centers, where parcel and vehicle inspections are limited due to staffing shortages and other constraints, experts and officials said.

"The U.S. Postal Service is aggressively working to implement provisions of the STOP Act to keep dangerous drugs from entering the United States from China and other countries," USPS said in a statement, referring to Synthetics Trafficking and Overdose Prevention Act enacted by U.S. Congress in 2018.

That legislation required the Postal Service to receive advance electronic data (AED) - including the names and addresses of senders and recipients, package contents and other information - on all shipments from China by the end of 2018 and from all countries by the end of 2020.

China's STOP compliance has lagged and the USPS and U.S. Customs and Border Protection (CBP) have informed China's postal operator any U.S.-bound shipment without AED may be returned at any time, the postal carrier said.

Meanwhile, USPS and its law enforcement arm, the Postal Inspection Service, continue to work with government and law enforcement agencies to combat the trafficking of illicit drugs like fentanyl, USPS said.

Amazon did not reply to a request for comment.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.